Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children Article

Drilon, A, Laetsch, TW, Kummar, S et al. (2018). Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children . NEW ENGLAND JOURNAL OF MEDICINE, 378(8), 731-739. 10.1056/NEJMoa1714448

Open Access ESI Most Cited Paper International Collaboration

cited authors

  • Drilon, A; Laetsch, TW; Kummar, S; DuBois, SG; Lassen, UN; Demetri, GD; Nathenson, M; Doebele, RC; Farago, AF; Pappo, AS; Turpin, B; Dowlati, A; Brose, MS; Mascarenhas, L; Federman, N; Berlin, J; El-Deiry, WS; Baik, C; Deeken, J; Boni, V; Nagasubramanian, R; Taylor, M; Rudzinski, ER; Meric-Bernstam, F; Sohal, DPS; Ma, PC; Raez, LE; Hechtman, JF; Benayed, R; Ladanyi, M; Tuch, BB; Ebata, K; Cruickshank, S; Ku, NC; Cox, MC; Hawkins, DS; Hong, DS; Hyman, DM

sustainable development goals

authors

publication date

  • February 22, 2018

published in

keywords

  • ACQUIRED-RESISTANCE
  • CARCINOMA
  • CELL LUNG-CANCER
  • ETV6-NTRK3 GENE FUSION
  • General & Internal Medicine
  • Life Sciences & Biomedicine
  • Medicine, General & Internal
  • SOLID TUMORS
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • MASSACHUSETTS MEDICAL SOC

start page

  • 731

end page

  • 739

volume

  • 378

issue

  • 8